Truist Financial Corp Sells 1,201,861 Shares of Aflac Incorporated (NYSE:AFL)

Truist Financial Corp decreased its holdings in Aflac Incorporated (NYSE:AFL) by 54.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 991,652 shares of the financial services provider’s stock after selling 1,201,861 shares during the quarter. Truist Financial Corp owned approximately 0.17% of Aflac worth $81,811,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of AFL. Impact Partnership Wealth LLC grew its stake in shares of Aflac by 471.4% in the third quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 330 shares during the last quarter. Czech National Bank grew its stake in shares of Aflac by 45.2% in the third quarter. Czech National Bank now owns 94,486 shares of the financial services provider’s stock worth $7,252,000 after purchasing an additional 29,395 shares during the last quarter. Asset Management One Co. Ltd. grew its stake in shares of Aflac by 1.9% in the third quarter. Asset Management One Co. Ltd. now owns 247,972 shares of the financial services provider’s stock worth $19,032,000 after purchasing an additional 4,653 shares during the last quarter. Aaron Wealth Advisors LLC bought a new stake in shares of Aflac in the third quarter worth $201,000. Finally, TFG Advisers LLC grew its stake in shares of Aflac by 13.3% in the third quarter. TFG Advisers LLC now owns 3,286 shares of the financial services provider’s stock worth $252,000 after purchasing an additional 386 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Insider Buying and Selling

In related news, Director Thomas J. Kenny sold 5,000 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the sale, the director now owns 17,920 shares in the company, valued at approximately $1,516,390.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the company’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the sale, the director now directly owns 17,920 shares of the company’s stock, valued at approximately $1,516,390.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Masatoshi Koide sold 30,493 shares of the company’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the completion of the sale, the director now directly owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The disclosure for this sale can be found here. Insiders have sold 46,493 shares of company stock worth $3,765,706 in the last quarter. Insiders own 0.90% of the company’s stock.

Aflac Stock Down 0.1 %

Shares of NYSE AFL traded down $0.12 during trading on Friday, hitting $83.61. 1,839,028 shares of the company traded hands, compared to its average volume of 2,169,786. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26. The firm has a market capitalization of $48.11 billion, a price-to-earnings ratio of 10.78, a P/E/G ratio of 2.30 and a beta of 0.91. The business’s fifty day moving average is $82.69 and its 200 day moving average is $81.75.

Aflac (NYSE:AFL) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a return on equity of 17.59% and a net margin of 24.92%. The business had revenue of $3.78 billion during the quarter, compared to analyst estimates of $4.44 billion. During the same quarter in the prior year, the company earned $1.29 EPS. Equities research analysts predict that Aflac Incorporated will post 6.41 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms recently issued reports on AFL. Raymond James boosted their target price on shares of Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Keefe, Bruyette & Woods boosted their target price on shares of Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a report on Wednesday, April 10th. Morgan Stanley boosted their target price on shares of Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Piper Sandler boosted their target price on shares of Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, April 5th. Finally, UBS Group boosted their target price on shares of Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, January 10th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $82.15.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.